A double-blind placebo-controlled study of an infusion of lexipafant (Platelet-activating factor receptor antagonist) in patients with severe sepsis. ανά Suputtamongkol, Y, Intaranongpai, S, Smith, MD, Angus, B, Chaowagul, W, Permpikul, C, Simpson, J, Leelarasamee, A, Curtis, L, White, N